NP35923 Cardiovascular & Respiratory Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £9K-£19M
- Sector
- HEALTH
- Published
- 25 Jul 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
46 suppliers
- Glaxosmithkline Brentford
- Martindale Pharma Romford
- Aventis Pharma Reading
- CST Pharma Walsall
- Day Lewis Medical Croydon
- Rovi Biotech Croydon
- Techdow Pharma England Guildford
- Tetris Pharma Marlow
- Accord Devon
- Mercury Pharma Group Croydon
- Esteve Pharmaceuticals Maidenhead
- Thornton & Ross Huddersfield
- Zentiva Pharma London
- Selective Supplies Haywards Heath
- Focus Pharmaceuticals Burton upon Trent
- Ennogen Healthcare Dartford
- Chiesi Manchester
- Glenmark Pharmaceuticals Europe Watford
- Sandoz Camberley
- Teva Castleford
- Wockhardt Wrexham
- Lupin Europe Knutsford
- Colonis Pharma Royal Tunbride Wells
- Pfizer Tadworth
- Leo Pharma Hurley
- Aop Orphan Birmingham
- DR Reddys Laboratories Cambridge
- Aguettant Bristol
- Aspire Pharma Petersfield
- Baxter Healthcare Berkshire
- Bowmed Ibisqus Wrexham
- Consilient Health Richmond
- Correvio Bielefeld
- Crescent Pharma Basingstoke
- Galen Craigavon
- Hameln Pharma Gloucester
- Kent Pharmaceuticals Ashford
- Morningside Pharmaceuticals Leicestershire
- Neon Healthcare Hertford
- Beaumont Pharma Henley on Thames
- Ranbaxy London
- Rosemont Pharmaceuticals Leeds
- Synchrony Pharma Stevenage
- Viatris UK Healthcare Hatfield
- RPH Pharma Cheadle
- PM Pharma Norwich
Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods were split into eighteen (18) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Division
| 2 | Epoprostenol powder and solvent (pH12) for solution for infusion vials Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded a multi-supplier unranked framework agreement for the Lot to a maximum of 6 Framework Participants. |
| 3 | Epinepherine (Adrenaline) Pre-filled syringes Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 5 | Enoxaparin Sodium Injection Supply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 7 | Isosorbide Mononitrate Modified Release Capsules and Tablets Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 8 | Diltiazem Hydrochloride Modified Release Capsules and Tablets Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 9 | Verapamil Hydrochloride Modified Release Capsules and Tablets Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 10 | Nifedipine Modified Release Capsules and Tablets Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 11 | Theophylline Modified Release Capsules and Tablets Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 12 | Branded and Branded Generic Inhalers Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 13 | Iloprost Medicines Supply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 14 | Dalteparin Injection Supply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 15 | Tinzaparin Sodium Injection Supply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 16 | Icatibant Solution for Injection Supply of Icatibant Solution for Injection to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 17 | Tresprostinil Injection Supply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis to a maximum of 6 Framework Participants. |
| 18 | All other Cardiovascular & Respiratory Medicines Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line was treated as an individual Lot. The Authority has awarded each product line to a single Framework Participant. |
Award Detail
| 1 | Glaxosmithkline (Brentford)
|
| 2 | Martindale Pharma (Romford)
|
| 3 | Aventis Pharma (Reading)
|
| 4 | CST Pharma (Walsall)
|
| 5 | Day Lewis Medical (Croydon)
|
| 6 | Rovi Biotech (Croydon)
|
| 7 | Techdow Pharma England (Guildford)
|
| 8 | Tetris Pharma (Marlow)
|
| 9 | Accord (Devon)
|
| 10 | Martindale Pharma (Romford)
|
| 11 | Mercury Pharma Group (Croydon)
|
| 12 | Esteve Pharmaceuticals (Maidenhead)
|
| 13 | Thornton & Ross (Huddersfield)
|
| 14 | Martindale Pharma (Romford)
|
| 15 | Aventis Pharma (Reading)
|
| 16 | Thornton & Ross (Huddersfield)
|
| 17 | Zentiva Pharma (London)
|
| 18 | Selective Supplies (Haywards Heath)
|
| 19 | Mercury Pharma Group (Croydon)
|
| 20 | Thornton & Ross (Huddersfield)
|
| 21 | Focus Pharmaceuticals (Burton upon Trent)
|
| 22 | Ennogen Healthcare (Dartford)
|
| 23 | Accord (Devon)
|
| 24 | Chiesi (Manchester)
|
| 25 | Day Lewis Medical (Croydon)
|
| 26 | Glaxosmithkline (Brentford)
|
| 27 | Glenmark Pharmaceuticals Europe (Watford)
|
| 28 | Sandoz (Camberley)
|
| 29 | Selective Supplies (Haywards Heath)
|
| 30 | Teva (Castleford)
|
| 31 | Thornton & Ross (Huddersfield)
|
| 32 | Zentiva Pharma (London)
|
| 33 | Wockhardt (Wrexham)
|
| 34 | Lupin Europe (Knutsford)
|
| 35 | Colonis Pharma (Royal Tunbride Wells)
|
| 36 | Zentiva Pharma (London)
|
| 37 | Pfizer (Tadworth)
|
| 38 | Leo Pharma (Hurley)
|
| 39 | Glenmark Pharmaceuticals Europe (Watford)
|
| 40 | Martindale Pharma (Romford)
|
| 41 | Sandoz (Camberley)
|
| 42 | Aop Orphan (Birmingham)
|
| 43 | DR Reddys Laboratories (Cambridge)
|
| 44 | Accord (Devon)
|
| 45 | Aguettant (Bristol)
|
| 46 | Aspire Pharma (Petersfield)
|
| 47 | Aventis Pharma (Reading)
|
| 48 | Baxter Healthcare (Berkshire)
|
| 49 | Bowmed Ibisqus (Wrexham)
|
| 50 | Chiesi (Manchester)
|
| 51 | Consilient Health (Richmond)
|
| 52 | Correvio (Bielefeld)
|
| 53 | Crescent Pharma (Basingstoke)
|
| 54 | CST Pharma (Walsall)
|
| 55 | Day Lewis Medical (Croydon)
|
| 56 | DR Reddys Laboratories (Cambridge)
|
| 57 | Ennogen Healthcare (Dartford)
|
| 58 | Focus Pharmaceuticals (Burton upon Trent)
|
| 59 | Galen (Craigavon)
|
| 60 | Glenmark Pharmaceuticals Europe (Watford)
|
| 61 | Hameln Pharma (Gloucester)
|
| 62 | Esteve Pharmaceuticals (Maidenhead)
|
| 63 | Kent Pharmaceuticals (Ashford)
|
| 64 | Lupin Europe (Knutsford)
|
| 65 | Martindale Pharma (Romford)
|
| 66 | Mercury Pharma Group (Croydon)
|
| 67 | Morningside Pharmaceuticals (Leicestershire)
|
| 68 | Neon Healthcare (Hertford)
|
| 69 | Beaumont Pharma (Henley on Thames)
|
| 70 | Pfizer (Tadworth)
|
| 71 | Ranbaxy (London)
|
| 72 | Rosemont Pharmaceuticals (Leeds)
|
| 73 | Sandoz (Camberley)
|
| 74 | Selective Supplies (Haywards Heath)
|
| 75 | Synchrony Pharma (Stevenage)
|
| 76 | Teva (Castleford)
|
| 77 | Thornton & Ross (Huddersfield)
|
| 78 | Viatris UK Healthcare (Hatfield)
|
| 79 | Wockhardt (Wrexham)
|
| 80 | Zentiva Pharma (London)
|
| 81 | RPH Pharma (Cheadle)
|
| 82 | PM Pharma (Norwich)
|
Award Criteria
| Logistics | 5 |
| price | 95 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value referred to in Section II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options of the Framework Agreement. The Goods within this procurement were separated and advertised as eighteen (18) categories, each of which was identified as a “Lot”. Out of the 18 lots, 15 Lots have been awarded. For details of lots not awarded, or details of individual lines awarded within a lot contact the named person at head of notice. (SC Ref:737798)
Reference
- ocds-h6vhtk-03967f
- FTS 021408-2023